IL-15: from discovery to FDA approval

Affiliations

• ¹ Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, 43210, USA.
• ² Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
• ³ Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, 43210, USA.
• ⁴ Division of Hematology and Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA.
• ⁵ Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, 29425, USA.
• ⁶ Immunology Division, Garvan Institute of Medical Research, Darlinghurst, 2010, Australia.
• ⁷ St. Vincent's Clinical School, University of New South Wales, Sydney, 1466, Australia.
• ⁸ Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, 43210, USA. mark.rubinstein@osumc.edu.
• ⁹ Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA. mark.rubinstein@osumc.edu.